The diverse role of RIP kinases in necroptosis and inflammation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Immunology

• Publication date

  2015-06-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ni.3206PMID 26086143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ubiquitin-modifying enzyme A20 restricts the ubiquitination of RIPK3 and protects cells from necroptosis

  2015cited by this paper
• A RIPK3–Caspase 8 Complex Mediates Atypical Pro–IL-1β Processing

  2015cited by this paper
• RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

  2015cited by this paper
• Herpes simplex virus suppresses necroptosis in human cells.

  2015cited by this paper
• Suppression of RIP3-dependent Necroptosis by Human Cytomegalovirus

  2015cited by this paper
• A novel function of RIP1 in postnatal development and immune homeostasis by protecting against RIP3-dependent necroptosis and FADD-mediated apoptosis

  2015cited by this paper
• RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice.

  2015cited by this paper
• IAP gene deletion and conditional knockout models.

  2015cited by this paper
• RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis

  2014cited by this paper
• RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.

  2014cited by this paper
• RIP3 induces apoptosis independent of pronecrotic kinase activity.

  2014cited by this paper
• Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis

  2014cited by this paper
• Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death

  2014cited by this paper
• Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis

  2014cited by this paper
• RIPK1 can function as an inhibitor rather than an initiator of RIPK3‐dependent necroptosis

  2014cited by this paper
• Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense

  2014cited by this paper
• PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK 1-and RIPK 3-dependent manner

  2014cited by this paper
• RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis

  2014cited by this paper
• RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.

  2014cited by this paper
• Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

  2014cited by this paper
• Synchronized renal tubular cell death involves ferroptosis

  2014cited by this paper
• FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes

  2014cited by this paper
• HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death.

  2014cited by this paper
• Necroptosis induced by RIPK3 requires MLKL but not Drp1

  2014cited by this paper
• Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

  2014cited by this paper
• Necroptosis Takes Place in Human Immunodeficiency Virus Type-1 (HIV-1)-Infected CD4+ T Lymphocytes

  2014cited by this paper
• Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death

  2014cited by this paper
• TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice

  2014cited by this paper
• Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling

  2014cited by this paper
• Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

  2014cited by this paper
• Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis

  2014cited by this paper
• MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates.

  2014cited by this paper
• Control of life-or-death decisions by RIP1 kinase.

  2014cited by this paper
• Concepts of tissue injury and cell death in inflammation: a historical perspective

  2014cited by this paper
• The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge.

  2014cited by this paper
• Pyroptotic death storms and cytopenia.

  2014cited by this paper
• RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition

  2014cited by this paper
• RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis

  2014cited by this paper
• Protective roles for caspase-8 and cFLIP in adult homeostasis.

  2013cited by this paper
• A role of RIP3-mediated macrophage necrosis in atherosclerosis development.

  2013cited by this paper
• Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis

  2013cited by this paper
• Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation

  2013cited by this paper
• Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury

  2013cited by this paper
• RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation.

  2013cited by this paper
• Necroptosis: the release of damage-associated molecular patterns and its physiological relevance.

  2013cited by this paper
• Absence of receptor interacting protein kinase 3 prevents ethanol‐induced liver injury

  2013cited by this paper
• Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells.

  2013cited by this paper
• Concepts of tissue injury and cell death in inflammation: a historical perspective

  2013cited by this paper
• The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

  2013cited by this paper
• Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome.

  2013cited by this paper
• Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis

  2013cited by this paper
• Masters, marionettes and modulators: intersection of pathogen virulence factors and mammalian death receptor signaling.

  2013cited by this paper
• Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration

  2013cited by this paper
• Receptor Interacting Protein Kinase-Mediated Necrosis Contributes to Cone and Rod Photoreceptor Degeneration in the Retina Lacking Interphotoreceptor Retinoid-Binding Protein

  2013cited by this paper
• Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

  2013cited by this paper
• RIPK3‐Mediated Necroptosis Promotes Donor Kidney Inflammatory Injury and Reduces Allograft Survival

  2013cited by this paper
• Proapoptotic Chemotherapeutic Drugs Induce Noncanonical Processing and Release of IL-1β via Caspase-8 in Dendritic Cells

  2013cited by this paper
• Dichotomy between RIP1- and RIP3-Mediated Necroptosis in Tumor Necrosis Factor-α-Induced Shock

  2012cited by this paper
• IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

  2012cited by this paper
• Breast cancer: Reprogramming ERα

  2012cited by this paper
• Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration

  2012cited by this paper
• IAPs limit activation of RIP kinases by TNF receptor 1 during development

  2012cited by this paper
• DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.

  2012cited by this paper
• Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1.

  2012cited by this paper
• Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models

  2012cited by this paper
• The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis.

  2012cited by this paper
• Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium

  2012cited by this paper
• Pathogen-Mediated Proteolysis of the Cell Death Regulator RIPK1 and the Host Defense Modulator RIPK2 in Human Aortic Endothelial Cells

  2012cited by this paper
• Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.

  2012cited by this paper
• Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury.

  2012cited by this paper
• Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1β and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner

  2012cited by this paper
• Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo

  2012cited by this paper
• Survival function of the FADD-CASPASE-8-cFLIP(L) complex.

  2012cited by this paper
• Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation.

  2012cited by this paper
• Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

  2012cited by this paper
• Faculty Opinions recommendation of Functional complementation between FADD and RIP1 in embryos and lymphocytes.

  2011cited by this paper
• FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity.

  2011cited by this paper
• Interleukin-33 biology with potential insights into human diseases

  2011cited by this paper
• Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways

  2011cited by this paper
• Necrostatin Decreases Oxidative Damage, Inflammation, and Injury after Neonatal HI

  2011cited by this paper
• cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms

  2011cited by this paper
• The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation.

  2011cited by this paper
• FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation

  2011cited by this paper
• Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis

  2011cited by this paper
• RIP3 mediates the embryonic lethality of caspase-8-deficient mice

  2011cited by this paper
• The regulation of TNF signalling: what a tangled web we weave.

  2011cited by this paper
• RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome.

  2011cited by this paper
• Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease

  2011cited by this paper
• Linear ubiquitination prevents inflammation and regulates immune signalling

  2011cited by this paper
• RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

  2011cited by this paper
• Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation

  2010cited by this paper
• Virus inhibition of RIP3-dependent necrosis.

  2010cited by this paper
• Regulation of death receptor signaling by the ubiquitin system

  2010cited by this paper
• Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs

  2010cited by this paper
• The inflammasomes.

  2010cited by this paper
• Anti-TNF Therapy, from Rationale to Standard of Care: What Lessons Has It Taught Us?

  2010cited by this paper
• Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

  2009cited by this paper
• The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

  2009cited by this paper
• Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment

  2009cited by this paper
• Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

  2009cited by this paper

• Metadynamics Simulation Reveals Allosteric Communication Effects of the Flipping Process of the Atypical DLG Motif in RIPK1.

  2026cites this paper
• Comprehensive pan-cancer analysis of the receptor-interacting protein kinase family expression, genomic alterations, and functional implications

  2026cites this paper
• Design, synthesis, and anti-necroptotic activity of novel Phenylbenzothiazole receptor-interacting protein kinase 1 (RIPK1) inhibitors.

  2026cites this paper
• Z-DNA binding protein 1 mediates necroptotic cell death in primary murine microglia following herpes simplex virus-1 infection

  2026cites this paper
• Targeting PANoptosis in atherosclerosis: bridging cell death mechanisms and therapy

  2026cites this paper
• Receptor-Interacting Protein Kinase 1 (RIPK1): A Potential Therapeutic Target in Ischemic Stroke

  2026cites this paper
• TNF-alpha: Roles in Pathogenesis and Therapeutics in Cancer.

  2026cites this paper
• Fibrillarin: bridging ribosome biogenesis and apoptosis in cellular stress and disease

  2026cites this paper
• From Hit to Lead: Discovery of Novel Selective RIPK1 Inhibitor with Pyridoimidazole Scaffold for the Treatment of Autoimmune Diseases through Phenotypic Screening and Structural Optimization.

  2026cites this paper
• Spotted: RIPK3 and MLKL assembling necroptotic complexes.

  2026cites this paper
• The Interplay of Aging and PANoptosis in Osteoarthritis Pathogenesis: Implications for Novel Therapeutic Strategies

  2025cites this paper
• Understanding the influence of TLR-Mediated Immune System on Necroptosis-Induced Neurodegeneration in Parkinson's Disease.

  2025cites this paper
• Comparative Efficacy of Different Targeted Therapies in Patients With Moderate‐to‐Severe Ulcerative Colitis: Systematic Review/Network Meta‐Analysis and Mechanistic Overview

  2025cites this paper
• Discovery and Characterization of Novel Receptor-Interacting Protein Kinase 1 Inhibitors Using Deep Learning and Virtual Screening.

  2025cites this paper
• Oligomerised RIPK1 is the main core component of the CD95 necrosome

  2025cites this paper
• Macrophage regulated cell death: implications and mechanisms in organ transplantation

  2025cites this paper
• TET2 promotes UVB-induced cell death by activating RIPK3-MLKL-necroptosis signaling.

  2025cites this paper
• The function of necroptosis in liver cancer.

  2025cites this paper
• Andrographolide prevents necroptosis by suppressing the generation of reactive oxygen species

  2025cites this paper
• DSTYK phosphorylates STING at late endosomes to promote STING signaling

  2025cites this paper
• Discovery of a 1H-Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory Disease.

  2025cites this paper
• Inflammatory adhesion mediates myocardial segmental necroptosis induced by mixed lineage kinase domain-like protein in acute myocardial infarction

  2025cites this paper
• A patent review of MLKL modulators (2023 – present)

  2025cites this paper
• Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acutely decompensated cirrhosis.

  2025cites this paper
• RIPK3 promotes skin inflammation by enhancing IL-36α signaling and necroptosis in keratinocytes

  2025cites this paper
• Targeting RIPK1 to modulate cell death and tumour microenvironment in cancer therapy

  2025cites this paper
• RIPK1 signaling pathways: implications for autoimmune and neuroinflammatory diseases

  2025influential citation
• STING induces ZBP1-mediated necroptosis independently of TNFR1 and FADD

  2025cites this paper
• Macrophage-endothelial cell crosstalk drives atherosclerotic plaque formation and progression.

  2025cites this paper
• RIPK1 ablation in T cells results in spontaneous enteropathy and TNF-driven villus atrophy

  2025cites this paper
• Procyanidin Capsules Combat ALF by Restoring Mitochondrial Homeostasis and Inhibiting Necroptosis via the PGAM5/DRP1/PINK1 Pathway

  2025cites this paper
• Preeclampsia is Associated with Altered Expression of Ferroptosis Biomarkers in Placental but not Maternal Vasculature

  2025cites this paper
• The proteomic landscape of blood monocytes in community-acquired pneumonia

  2025cites this paper
• Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8

  2025cites this paper
• Wiring and rewiring PANoptosis: Molecular vulnerabilities for targeting inflammatory cell death in human disease.

  2025cites this paper
• Phosphoglycerate Mutase 5 Is Important Mediator for Instigating Arterial Lipid Accumulation and Aggravating Atherosclerosis

  2025cites this paper
• Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS

  2025cites this paper
• Design, Optimization and Development of RIPK1 Degraders with Improved Pharmacokinetic and Pharmacodynamic Properties

  2025cites this paper
• Unraveling the intriguing interplay: Exploring the role of lncRNAs in caspase‐independent cell death

  2024cites this paper
• The role of programmed cell death in osteosarcoma: From pathogenesis to therapy

  2024cites this paper
• Astragalin protects against lipopolysaccharide-triggered acute liver injury through suppression of necroptosis and inflammation and improvement of energy metabolism

  2024cites this paper
• Ultrastructural and immunohistochemical evaluation of hyperplastic soft tissues surrounding dental implants in fibular jaws

  2024cites this paper
• Development of Biochemical and Cellular Probes to Study RIPK1 Target Engagement.

  2024cites this paper
• RIPK3 signaling and its role in regulated cell death and diseases

  2024cites this paper
• Necroptosis pathway emerged as potential diagnosis markers in spinal cord injury

  2024cites this paper
• Cellular heterogeneity in TNF/TNFR1 signalling: live cell imaging of cell fate decisions in single cells

  2024cites this paper
• GSK'872 improves prognosis of traumatic brain injury by switching RIP3-dependent necroptosis to Caspase-8-dependent apoptosis.

  2024cites this paper
• Functional characterization of RIP2 in large yellow croaker (Larimichthys crocea), a protein involved in the host antiviral responses via NF-κΒ, IRF3/7 related signaling.

  2024cites this paper
• Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity

  2024cites this paper
• Outer membrane vesicles of avian pathogenic Escherichia coli induce necroptosis and NF-κB activation in chicken macrophages via RIPK1 mediation.

  2024cites this paper
• The autophagy protein RUBCNL/PACER represses RIPK1 kinase-dependent apoptosis and necroptosis

  2024cites this paper
• Role of hepatocyte RIPK1 in maintaining liver homeostasis during metabolic challenges

  2024cites this paper
• Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases.

  2024cites this paper
• Synthesis and preclinical evaluation of 11C-labeled 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine radioligands for RIPK1 positron emission tomography imaging.

  2024cites this paper
• The Complexity of Being A20: From Biological Functions to Genetic Associations

  2024cites this paper
• A bibliometric analysis of the research hotspots and frontiers related to cell death in spinal cord injury

  2024cites this paper
• Processing of angiocrine alarmin IL-1α in endothelial cells promotes lung and liver fibrosis.

  2024cites this paper
• Metabolic changes enhance necroptosis of type 2 diabetes mellitus mice infected with Mycobacterium tuberculosis

  2024cites this paper
• Regulated Cell death in Acute Myocardial Infarction: Molecular Mechanisms and Therapeutic Implications.

  2024cites this paper
• Human adipose-derived stem cells genetically programmed to induce necroptosis for cancer immunotherapy

  2024cites this paper
• Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury

  2024cites this paper
• Microbiota-associated mechanisms in colorectal cancer.

  2024cites this paper
• The interplay between cell death and senescence in cancer.

  2024cites this paper
• Safety and efficacy of selective RIPK1 inhibitor SIR1-365 in hospitalized patients with severe COVID-19: A multicenter, randomized, double-blind, phase 1b trial

  2024cites this paper
• Structure-based discovery of a 4,5-Dihydropyrazole-cored PET ligand for imaging of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in the brain.

  2024cites this paper
• Significance of Necroptosis in Cartilage Degeneration

  2024cites this paper
• Molecular mechanisms of hepatic lipid metabolism disorders: Focus on mitochondrial quality control

  2024cites this paper
• Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease

  2024cites this paper
• cGAS-ISG15-RAGE axis reprogram necroptotic microenvironment and promote lymphatic metastasis in head and neck cancer

  2024cites this paper
• Imbalance of programmed cell death patterns mediated by dendritic cell subsets in systemic lupus erythematosus and lupus nephritis

  2024cites this paper
• A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury

  2024cites this paper
• Investigating the Interplay between Mitophagy and Diabetic Neuropathy: Uncovering the hidden secrets of the disease pathology.

  2024cites this paper
• Integrin A5B1-mediated endocytosis of polystyrene nanoplastics: Implications for human lung disease and therapeutic targets.

  2024cites this paper
• Design, synthesis, and preclinical evaluation of 11C/18F-labeled inhibitors for RIPK1 PET imaging.

  2024cites this paper
• Macrophage Perspectives in Liver Diseases: Programmed Death, Related Biomarkers, and Targeted Therapy

  2024cites this paper
• Targeting caspase-8/c-FLIPL heterodimer in complex II promotes DL-mediated cell death

  2024cites this paper
• Nematodes exposed to furfural acetone exhibit a species-specific vacuolar H+-ATPase response.

  2024cites this paper
• Residue Y362 is crucial for FLIPL to impart catalytic activity to pro-caspase-8 to suppress necroptosis.

  2024cites this paper
• Discovery of Covalent MLKL PROTAC Degraders via Optimization of a Theophylline Derivative Ligand for Treating Necroptosis.

  2024cites this paper
• A necroptosis-independent function of RIPK3 promotes immune dysfunction and prevents control of chronic LCMV infection

  2023cites this paper
• SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine Signaling

  2023cites this paper
• Mixed lineage kinase domain-like pseudokinase: Conventional (necroptosis) and unconventional (necroptosis-independent) functions and features.

  2023cites this paper
• Mitochondrial pores at the crossroad between cell death and inflammatory signaling.

  2023cites this paper
• High Glucose-Induced Kidney Injury via Activation of Necroptosis in Diabetic Kidney Disease

  2023cites this paper
• Paricalcitol Ameliorates Acute Kidney Injury in Mice by Suppressing Oxidative Stress and Inflammation via Nrf2/HO-1 Signaling

  2023cites this paper
• Programmed cell death and lipid metabolism of macrophages in NAFLD

  2023cites this paper
• Kinases control of Regulated Cell Death Revealing Druggable Targets for Parkinson's disease.

  2023cites this paper
• From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases.

  2023cites this paper
• SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses

  2023cites this paper
• OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis

  2023cites this paper
• Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors.

  2023cites this paper
• Discovery of novel 5-phenylpyrazol receptor interacting protein 1(RIP1) kinase inhibitors as anti-necroptosis agents by combining virtual screening and in vitro and in vivo experimental evaluations.

  2023cites this paper
• A novel necroptosis-related model predicts the prognosis and immunocompetence of head and neck squamous cell carcinoma.

  2023cites this paper
• SeMet alleviates LPS-induced eggshell gland necroptosis mediated inflammation by regulating the Keap1/Nrf2/HO-1 pathway.

  2023cites this paper
• Targeting necroptosis in fibrosis

  2023cites this paper
• Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity.

  2023cites this paper
• RIPK1 deficiency prevents thymic NK1.1 expression and subsequent iNKT cell development

  2023cites this paper
• Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)

  2023influential citation
• Novel isobavachalcone derivatives induce apoptosis and necroptosis in human non-small cell lung cancer H1975 cells

  2023cites this paper
• Regulated cell death in musculoskeletal development, homeostasis, and diseases

  2023cites this paper